Therapeutic Options for the SARS-CoV-2 Virus: Is There a Key in Herbal Medicine?

Abstract

SARS-CoV-2 has been responsible for over 500 million cumulative cases all over the world since December 2019 and has marked the third introduction of a highly pathogenic virus after SARS-CoV and MERS-CoV. This virus is in a winning situation because scientists are still racing to explore effective therapeutics, vaccines, and event treatment regimens. In view of progress in current disease management, until now none of the preventive/treatment measures can be considered entirely effective to treat SARS-CoV-2 infection. Therefore, it is required to look up substitute ways for the management of this disease. In this context, herbal medicines could be a good choice. This article emphasizes the antiviral potential of some herbal constituents which further can be a drug of choice in SARS-CoV-2 treatment. This article may be a ready reference for discovering natural lead compounds and targets in SARS-CoV-2 associated works.

Medical oxygen: Sources and regulatory guidelines

“…It frequently happens in unstructured or unrestricted environments, leading to hyperoxia and oxygen toxicity consequences. [6] The significance of receiving the best oxygen therapy cannot be compromised. This review is explaining the various aspects of medical oxygen such as sources, usage, and supervision.…”

Phytochemicals Against SARS-COV-2 Infection

“…However, still more phytoconstituents should be studied through proper clinical trials to find more effective anti-SARS-CoV treatments. 5 Angiotensin-converting enzyme 2 (ACE2), an entry receptor of the SARS-CoV-2 virus, is also responsible for various neurological dysfunctions that are associated with COVID-19 in patients. To treat the neurological manifestations associated with the ACE2 receptor, Hou et al discerned that andrographolide and 14-deoxy-11,12-didehydroandrographolide, constituents of Andrographis paniculata, bind effectively with the ACE2 receptor and must be further clinically validated for treating neurological manifestations associated with the ACE2 receptor in COVID-19.…”

“…However, still more phytoconstituents should be studied through proper clinical trials to find more effective anti-SARS-CoV treatments. 5…”